Innovative use of gram-positive enhancer matrix particles and affinity peptides in a vaccine against Coxsackievirus B3
Viral myocarditis (VM) is an inflammatory disease posing a serious threat to public health, with various viral pathogens contributing to its pathogenesis. Coxsackievirus B3 (CVB3) is the most frequently implicated causative agent and has been extensively studied because of its high prevalence and se...
Saved in:
| Main Authors: | Shaoju Qian, Ruixue Li, Guanyu Chen, Yinghua Ma, Xuehan Zhang, Zhou Tang, Yihang Song, Zhishan Xu, Zihan Zhang, Yeqing He, Xingyi Zhang, Shuao Lu, Zishan Yang, Xiangfeng Song, Wenfa Yu, Lili Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Virulence |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21505594.2025.2481657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection and identification of coxsackievirus B3 from sera of an Indonesian patient with undifferentiated febrile illness
by: Ageng Wiyatno, et al.
Published: (2016-08-01) -
Coxsackieviruses B1–6 as Etiological Factor of Enterovirus Infection
by: N. I. Romanenkova, et al.
Published: (2016-07-01) -
Recent advances on coxsackievirus A6 vaccine research
by: Xianfeng Zhou, et al.
Published: (2025-06-01) -
A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs
by: Zhenjie Zhang, et al.
Published: (2019-01-01) -
Unraveling the molecular basis of membrane-associated release of coxsackievirus B3
by: Rodrigo Arce, et al.
Published: (2025-03-01)